We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
NextNav
NN
$1.73B
| $3.89K | ﹤0.01% |
218
-196
| -47% | -$3.79K |
|
2477
SFL Corp
SFL
$1.58B
| $3.88K | ﹤0.01% |
380
| – | – |
|
2478
SITE Centers
SITC
$224M
| $3.87K | ﹤0.01% |
+974
| New | +$5.08K |
|
2479
Cullen/Frost Bankers
CFR
$10.1B
| $3.86K | ﹤0.01% |
25
| – | – |
|
2480
WIX.com
WIX
$2.04B
| $3.86K | ﹤0.01% |
85
-1,891
| -96% | -$117K |
|
2481
Laureate Education
LAUR
$5.12B
| $3.85K | ﹤0.01% |
106
| – | – |
|
2482
Korea Electric Power
KEP
$15.5B
| $3.81K | ﹤0.01% |
315
+187
| +146% | +$2.58K |
|
2483
Azenta
AZTA
$1.3B
| $3.78K | ﹤0.01% |
148
+14
| +10% | +$314 |
|
|
TBCH
2484
Turtle Beach Corp
TBCH
$241M
| $3.76K | ﹤0.01% |
302
-1,012
| -77% | -$12K |
|
2485
BrightView Holdings
BV
$1.32B
| $3.75K | ﹤0.01% |
265
-345
| -57% | -$4.33K |
|
|
CHCT
2486
Community Healthcare Trust
CHCT
$529M
| $3.75K | ﹤0.01% |
205
| – | – |
|
2487
Cognition Therapeutics
CGTX
$85.9M
| $3.75K | ﹤0.01% |
3,257
+184
| +6% | +$218 |
|
2488
Kura Sushi USA
KRUS
$548M
| $3.74K | ﹤0.01% |
65
-64
| -50% | -$3.5K |
|
|
MCHB
2489
Mechanics Bancorp
MCHB
$3.53B
| $3.69K | ﹤0.01% |
232
| – | – |
|
|
NLOP
2490
Net Lease Office Properties
NLOP
$173M
| $3.66K | ﹤0.01% |
329
+272
| +477% | +$3.28K |
|
2491
Build-A-Bear
BBW
$424M
| $3.64K | ﹤0.01% |
119
-227
| -66% | -$8.14K |
|
2492
TFS Financial
TFSL
$5.09B
| $3.62K | ﹤0.01% |
204
| – | – |
|
|
ALH
2493
Alliance Laundry Holdings
ALH
$5B
| $3.61K | ﹤0.01% |
+136
| New | +$3.4K |
|
2494
Peoples Bancorp
PEBO
$1.43B
| $3.57K | ﹤0.01% |
93
| – | – |
|
|
UNIT
2495
Uniti Group
UNIT
$2.68B
| $3.57K | ﹤0.01% |
311
| – | – |
|
|
RNA
2496
Atrium Therapeutics
RNA
$204M
| $3.56K | ﹤0.01% |
+265
| New | +$3.46K |
|
|
AMTM
2497
Amentum Holdings
AMTM
$5.38B
| $3.54K | ﹤0.01% |
171
-113
| -40% | -$2.73K |
|
2498
Ocular Therapeutix
OCUL
$1.89B
| $3.52K | ﹤0.01% |
359
+129
| +56% | +$1.17K |
|
2499
Liberty Energy
LBRT
$3.2B
| $3.51K | ﹤0.01% |
134
| – | – |
|
2500
Hippo Holdings
HIPO
$714M
| $3.5K | ﹤0.01% |
124
| – | – |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.